| Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) PW Sperduto, TJ Yang, K Beal, H Pan, PD Brown, A Bangdiwala, ... JAMA oncology 3 (6), 827-831, 2017 | 639 | 2017 |
| Phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human papillomavirus–associated oropharynx squamous cell carcinoma DJ Ma, KA Price, EJ Moore, SH Patel, ML Hinni, JJ Garcia, DE Graner, ... Journal of Clinical Oncology 37 (22), 1909-1918, 2019 | 194 | 2019 |
| A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K DJ Ma, E Galanis, SK Anderson, D Schiff, TJ Kaufmann, PJ Peller, ... Neuro-oncology 17 (9), 1261-1269, 2015 | 166 | 2015 |
| Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma RA Vaubel, S Tian, D Remonde, MA Schroeder, AC Mladek, GJ Kitange, ... Clinical Cancer Research 26 (5), 1094-1104, 2020 | 143 | 2020 |
| Complications of fluoroscopically guided extraforaminal cervical nerve blocks: an analysis of 1036 injections DJ Ma III, LA Gilula, KD Riew JBJS 87 (5), 1025-1030, 2005 | 136 | 2005 |
| Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial N Riaz, E Sherman, X Pei, H Schöder, M Grkovski, R Paudyal, N Katabi, ... JNCI: Journal of the National Cancer Institute 113 (6), 742-751, 2021 | 127 | 2021 |
| Conditional probability of long‐term survival in glioblastoma: a population‐based analysis DR Johnson, DJ Ma, JC Buckner, JE Hammack Cancer 118 (22), 5608-5613, 2012 | 122 | 2012 |
| Survival in response to multimodal therapy in anaplastic thyroid cancer N Prasongsook, A Kumar, AV Chintakuntlawar, RL Foote, J Kasperbauer, ... The Journal of Clinical Endocrinology & Metabolism 102 (12), 4506-4514, 2017 | 104 | 2017 |
| The effect of gene alterations and tyrosine kinase inhibition on survival and cause of death in patients with adenocarcinoma of the lung and brain metastases PW Sperduto, TJ Yang, K Beal, H Pan, PD Brown, A Bangdiwala, ... International Journal of Radiation Oncology* Biology* Physics 96 (2), 406-413, 2016 | 103 | 2016 |
| Stereotactic body radiotherapy for primary hepatic malignancies–report of a phase I/II institutional study AA Weiner, J Olsen, D Ma, P Dyk, T DeWees, RJ Myerson, P Parikh Radiotherapy and Oncology 121 (1), 79-85, 2016 | 81 | 2016 |
| Clinically applicable Monte Carlo–based biological dose optimization for the treatment of head and neck cancers with spot-scanning proton therapy HSWC Tseung, J Ma, CR Kreofsky, DJ Ma, C Beltran International Journal of Radiation Oncology* Biology* Physics 95 (5), 1535-1543, 2016 | 74 | 2016 |
| A phase 2 study of pembrolizumab combined with chemoradiotherapy as initial treatment for anaplastic thyroid cancer AV Chintakuntlawar, J Yin, RL Foote, JL Kasperbauer, M Rivera, E Asmus, ... Thyroid 29 (11), 1615-1622, 2019 | 69 | 2019 |
| Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma JL Geiger, AF Lazim, FJ Walsh, RL Foote, EJ Moore, SH Okuno, KD Olsen, ... Oral oncology 50 (4), 311-318, 2014 | 66 | 2014 |
| Revisiting adjuvant radiotherapy after gross total resection of World Health Organization grade II meningioma CS Graffeo, HE Leeper, A Perry, JH Uhm, DJ Lachance, PD Brown, ... World neurosurgery 103, 655-663, 2017 | 65 | 2017 |
| Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience ME Gamez, D Lal, MY Halyard, WW Wong, C Vargas, D Ma, SJ Ko, ... Head & neck 39 (9), 1819-1824, 2017 | 57 | 2017 |
| Tumor volume discrepancies between FDG-PET and MRI for cervical cancer DJ Ma, JM Zhu, PW Grigsby Radiotherapy and Oncology 98 (1), 139-142, 2011 | 54 | 2011 |
| MARQUIS: a multiplex method for absolute quantification of peptides and posttranslational modifications TG Curran, Y Zhang, DJ Ma, JN Sarkaria, FM White Nature communications 6 (1), 5924, 2015 | 52 | 2015 |
| Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules D Owen, KR Olivier, CS Mayo, RC Miller, K Nelson, H Bauer, PD Brown, ... Radiation Oncology 10, 1-8, 2015 | 51 | 2015 |
| Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults ME Gamez, R Kraus, ML Hinni, EJ Moore, DJ Ma, SJ Ko, JCM Rwigema, ... Oral oncology 87, 43-48, 2018 | 47 | 2018 |
| Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the … GS Manzar, SC Lester, DM Routman, WS Harmsen, MM Petersen, ... Radiotherapy and Oncology 147, 64-74, 2020 | 45 | 2020 |
